Mice Model Market, By Mice Type (Inbred, Outbred, Knockout, Hybrid and Others), By Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer and Others), By Application (Research & Development, Infectious Disease, Cancer, Cardiovascular Diseases, Genetic Diseases and Others), By End-User (Pharmaceutical, Biotechnology, Cosmetics, Contract Research Organizations (CRO) and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI487122 | Publish Date: March 2024 | No. of Pages: 168

Mice Model Market Overview

Mice Model Market accounted for US$ 1.54 billion in 2020 and is estimated to be US$ 2.77 billion by 2030 and is anticipated to register a CAGR of 6.10%.

A mouse model is a laboratory model that is used to study human physiology, biomedical science, and illness. It is utilised to research complicated conditions like hypertension and atherosclerosis. Mice are important in study since they are genetically identical to humans in 95 percent of cases. The use of mice models has expanded as a result of technological developments in gene editing, which has greatly benefited scientists in the discovery and development of innovative medications. These models are widely utilised in research studies in a variety of domains, including oncology and immunology. The market for genetically engineered humanised mice models has grown in response to the growing need for tailored medications.  

Impact of Covid-19 pandemic on market

The coronavirus epidemic that has resulted in the continuing COVID-19 pandemic is an unparalleled public health threat. Due to humans lack pre-existing immunity to SARS-CoV-2, there is a growing need for vaccines and therapeutic medicines to combat the current pandemic and avoid the reemergence of COVID-19. Due to the requirement to conduct research tests, the demand for humanised ACE2 mice models is increasing. As a result, government and scientific research institutes are likely to expand their research investments in the development of COVID-19 vaccines and therapies.

Mice Model Market Dynamics

Advances in gene editing techniques

The growth of the mice model business will be aided by advances in gene editing techniques. The CRISPR-associated protein (Cas9) technology, also known as clustered regularly interspaced short palindromic repeats, has revolutionised genome editing. Several unique applications of CRISPR/Cas9 in a wide spectrum of disorders have proved its efficacy, and in-vivo mouse models have been employed extensively. For example, using the CRISPR system to somatic cells of adult mice via viral delivery led in the creation of an Eml4-Alk-driven lung cancer mouse model to examine disease features. Incorporating Cas9 into mouse zygotes has also resulted in transgenic mice, which may be used to study the pathophysiology of cardiovascular disorders. The CRISPR-Cas9 system was also utilised to create Kcnj13 mutant mice for research into ocular illnesses.

Inbred mice model market sales exceeded, owing to increased use of inbred mice in pharmacology and cardiovascular disease research, as well as to analyse the reactions of monoclonal antibodies. Inbred mice have been proven to be effective instruments in genetic research of complicated disorders, resulting in an increase in inbred mouse demand. Due to uniformity of the genetic background, they are also used in transgenic research. Furthermore, inbred mice are less expensive than mutant humanised mice. They have a fully developed immune system, are genetically stable, and are cost effective.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Mice Model Market Segmentation

The Mice Model Market report segments the market on the basis of mice type, technology, application, end-user and region.

On the basis of Mice Type, the Mice Model Market is segmented into Inbred, Outbred, Knockout, Hybrid and Others. On the basis of Technology, the target market is segmented into CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer and Others. Based on Application, the market is segmented into Research & Development, Infectious Disease, Cancer, Cardiovascular Diseases, Genetic Diseases and Others. Based on End-User, the market is segmented into Pharmaceutical, Biotechnology, Cosmetics, Contract Research Organizations (CRO) and Others.

Regional Insights:

Mice Model Market accounted for US$ 1.54 billion in 2020 and is estimated to be US$ 2.77 billion by 2030 and is anticipated to register a CAGR of 6.10%.  On region the Mice Model Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. United States dominated the North American mice model market due to the high frequency of chronic diseases such as diabetes and viral diseases. Several research organisations in the country are concentrating on the development of effective therapeutic medications for viral illness therapy. In the United States, high-throughput mutagenesis projects are producing a huge number of mutant mouse models through the Knockout Mouse Project (KOMP). In order to address the need and supply of mouse models, the Mutant Mice Regional Resource Center (MMRRC) in the United States serves as a repository for mouse strains that are important for use in biomedical research. The presence of well-established industry players in the country, as well as state-of-the-art healthcare facilities, would further fuel market demand.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2029

Market representation

Revenue in USD Million & CAGR from 2020 – 2029

Market Segmentation

By Mice Type - Inbred, Outbred, Knockout, Hybrid and Others

By Technology – CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer and Others

By Application – Research & Development, Infectious Disease, Cancer, Cardiovascular Diseases, Genetic Diseases and Others

By End-User – Pharmaceutical, Biotechnology, Cosmetics, Contract Research Organizations (CRO) and Others

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at , regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Mice Model Market report based on mice type, technology, application, end-user and Region.

segmentation - Mice Model Market

Recent Highlights:

  • Merck granted GenOway exclusive worldwide rights to its basic CRISPR/Cas9 portfolio in the rodent industry in 2020.
  • Taconic and the University of Texas Medical Branch signed an agreement in 2020 to distribute humanised ACE2 mice for COVID-19 research.
  • The Jackson Laboratory began producing ACE2 mice in 2020 in order to aid COVID-19 research.
  • Oragenics Inc. and Aragen Bioscience have agreed to collaborate on the development of TerraCoV2, a SARS-CoV-2 (COVID-19) vaccine candidate, in 2020.
  • Innovive announced plans to expand its manufacturing facilities in North Sioux City, South Dakota, in 2020. (US).

Mice Model Market, By Region:

  • North America
    • Middle East & Africa
        • GCC
        • Israel
        • South Africa
    • Latin America
        • Brazil
        • Mexico
        • Rest of Latin America
    • Asia Pacific
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Europe
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • U.S.
    • Canada

Rest of Middle East & Africa

Mice Model Market Key Players

The key players operating in the Mice Model Market includes Charles River Laboratories, (US) The Jackson Laboratory (US), Taconic Biosciences, Inc. (US), Envigo (US), JANVIER LABS (France), genOway (France), PolyGene (Switzerland), Crown Biosciences (US), TransCure bioservices (France), Ingenious Targeting Laboratory (US), Cyagen Biosciences (US), GVK BIO (India), The Andersons, Inc. (US), Innovive (US), Allentown, LLC (US), FENGSHI Group (China), Ozgene Pty Ltd. (Australia), and Harbour Biomed (US).

Taconic Biosciences, Inc.

Taconic Biosciences is a private biotechnology firm that specializes in genetically altered mice and rat models, as well as microbiome, immuno-oncology, and integrated model design and breeding services. Taconic Farms, the company's original name, was formed in 1952. Taconic Biosciences released the first commercially developed NASH diet-induced (nonalcoholic steatohepatitis) mice model in July 2019.

Mice Model Market Company Profile

  • Charles River Laboratories
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • The Jackson Laboratory
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Taconic Biosciences, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • JANVIER LABS
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • genOway
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • PolyGene
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Crown Biosciences
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • TransCure bioservices
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Ingenious Targeting Laboratory
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Harbour Biomed
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

Mice Model Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Preview
    • Executive Summary
    • Key Findings—Global Outlook for Mice Model Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Mice Type
      • Market Snippet, By Technology
      • Market Snippet, By Application
      • Market Snippet, By End-User
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Market Segmentation, By Mice Type, 2020 – 2030, (US$ Mn)
    • Overview                     
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Inbred
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Outbred
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Knockout
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Hybrid
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Market Segmentation, By Technology, 2020 – 2030, (US$ Mn)
    • Overview                                      
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • CRISPR
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Microinjection
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Embryonic Stem Cell Injection
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Nuclear Transfer
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Market Segmentation, By Application, 2020 – 2030, (US$ Mn)
    • Overview                                      
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Research & Development
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Infectious Disease
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Cancer
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Cardiovascular Diseases
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Genetic Disease
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  8. Market Segmentation, By End-User, 2020 – 2030, (US$ Mn)
    • Overview                                               
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Pharmaceuticals
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Biotechnology
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Cosmetics
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Contract Research Organizations (CRO)
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  9. Global Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Mice Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Mice Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Mice Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Mice Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Mice Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  10. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  11. Company Profiles

 

  • Charles River Laboratories
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • The Jackson Laboratory
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Taconic Biosciences, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • JANVIER LABS
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • genOway
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • PolyGene
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Crown Biosciences
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • TransCure bioservices
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Ingenious Targeting Laboratory
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Harbour Biomed
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The Global Mice Model Market report segments the market on the basis of mice type, technology, application, end-user and region.

The growth of the mice model business will be aided by advances in gene editing techniques. The CRISPR-associated protein (Cas9) technology, also known as clustered regularly interspaced short palindromic repeats, has revolutionised genome editing.

United States dominated the North American mice model market due to the high frequency of chronic diseases such as diabetes and viral diseases.

The key players operating in the Global Mice Model Market includes Charles River Laboratories, (US) The Jackson Laboratory (US), Taconic Biosciences, Inc. (US), Envigo (US), JANVIER LABS (France), genOway (France), PolyGene (Switzerland), Crown Biosciences (US), TransCure bioservices (France), Ingenious Targeting Laboratory (US), Cyagen Biosciences (US), GVK BIO (India), The Andersons, Inc. (US), Innovive (US), Allentown, LLC (US), FENGSHI Group (China), Ozgene Pty Ltd. (Australia), and Harbour Biomed (US)